US to share Covid vaccine technology, Biden tells global summit | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Food
    • Habitat
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
The Business Standard

Saturday
December 02, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Food
    • Habitat
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
SATURDAY, DECEMBER 02, 2023
US to share Covid vaccine technology, Biden tells global summit

Coronavirus chronicle

Reuters
13 May, 2022, 10:15 am
Last modified: 13 May, 2022, 10:25 am

Related News

  • US memorandum on labour standard: Nothing to worry about, Momen says
  • Henry Kissinger, controversial US statesman, dies at 100
  • Over 13,000 Bangladeshis currently studying in the US, an all-time high
  • Gold inches higher as investors focus on US inflation data
  • Oil prices ease on worries of waning demand in US and China

US to share Covid vaccine technology, Biden tells global summit

Reuters
13 May, 2022, 10:15 am
Last modified: 13 May, 2022, 10:25 am
 Vials of the Pfizer-BioNTech coronavirus disease (Covid-19) pediatric vaccine are pictured in Lansdale, Pennsylvania, US, December 5, 2021. Photo :Reuters
Vials of the Pfizer-BioNTech coronavirus disease (Covid-19) pediatric vaccine are pictured in Lansdale, Pennsylvania, US, December 5, 2021. Photo :Reuters

The United States will share technologies used to make Covid-19 vaccines through the World Health Organization and is working to expand rapid testing and antiviral treatments for hard-to-reach populations, President Joe Biden said on Thursday.

Speaking at the second global Covid-19 summit, Biden called on Congress to provide additional funds so that the US may contribute more to the global pandemic response.

"We are making available health technologies that are owned by the United States government, including stabilised spike protein that is used in many Covid-19 vaccines," Biden said in his opening speech.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

The summit, jointly hosted by the United States, Belize, Germany, Indonesia and Senegal, is being held virtually on Thursday for countries to discuss efforts to end the pandemic and prepare for future health threats.

It is set to build on efforts and commitments made at the first global summit in September, including getting more people vaccinated, sending tests and treatments to highest-risk populations, expanding protections to health-care workers, and generating financing for pandemic preparedness.

It has gathered more than $3 billion in new funding to fight the pandemic, the White House said, including over $2 billion for immediate response and $962 million in commitments to the World Bank pandemic preparedness fund.

The contributions include the United States contributing an additional $200 million to a global health fund for future pandemic preparedness at the World Bank, bringing its total contribution to $450 million, it said.

The European Union said it was providing 300 million euros for vaccination support, and $450 million for the preparedness fund. NGOs, philanthropies, and the private sector made over $700 million in new commitments.

Several generic drugmakers that will produce versions of Pfizer's (PFE.N) Covid-19 antiviral treatment Paxlovid have agreed to sell the medicine in low- and middle-income countries for $25 a course or less, the Clinton Health Access Initiative (CHAI) said on Thursday.

At least 14 other countries as well as the WHO, European Commission, private-sector companies like Google (GOOGL.O), and non-governmental organizations, are attending the summit.

"This summit is an opportunity to renew our efforts, to keep our foot on the gas when it comes to getting this pandemic under control and preventing future health crises," Biden said.

He called on world leaders to consider how their countries could contribute further to the global pandemic response.

"That is why I continue to call on Congress here at home to take the urgent action to provide emergency Covid-19 funding," he said. "The request also includes $5 million to keep up our global partnership in the fight against Covid-19, to sustain our efforts to get shots in people's arms all around the world."

Biden has asked Congress for over $22.5 billion in additional Covid-19 response funds, including $5 billion for international aid, but lawmakers have failed to pass any funding bill and those negotiating the package have been unable to agree on how to pay for the global response.

While additional US funding may be stuck, the commitment to share 11 Covid-19 technologies with the UN-backed Medicines Patent Pool (MPP) should help improve access to vaccines, treatments, and tests in lower-income countries by allowing them to work on generic versions, the WHO said.

"It's through sharing and empowering lower-income countries to manufacture their own health tools that we can ensure a healthier future for everyone," said WHO Director General Tedros Adhanom Ghebreyesus.

The technologies will be licensed by the US National Institutes for Health to the WHO's Covid-19 Technology Access Pool (C-TAP) and the MPP, initiatives set up to share know-how with manufacturers all around the world, allowing them to work on generic versions of key Covid-19 tools.

Scientists at the NIH worked with Moderna (MRNA.O)to develop its Covid-19 shot.

The United States has delivered over 500 million doses of vaccines to over 100 countries as part of the 1.2 billion doses it pledged at the first summit in September and has already committed over $19 billion in funding for vaccines, tests, treatments, and other forms of assistance, Biden said.

"There is still so much left to do. This pandemic isn't over," said Biden. "Today, we mark a tragic milestone here in the United States, 1 million Covid deaths, 1 million empty chairs around a family dinner table. Each irreplaceable."

Top News

Coronavirus Vaccine / United States / patent

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Will Bangladeshi garment exporters be able to meet EU's upcoming standards?
    Will Bangladeshi garment exporters be able to meet EU's upcoming standards?
  • A file photo of Election Commission building. Photo: Collected
    EC asks govt to transfer OCs, UNOs ahead of election
  • Illustration: TBS
    4 parties deny fielding candidates after EC data shows their contestants

MOST VIEWED

  • Illustration: TBS
    I am afraid even to post a thank you note on Facebook: Khadija
  • File photo of Bangladesh Bank. Photo: Salahuddin Ahmed/TBS
    Remitters can now deposit in forex – with up to 9% interest
  • Mominul Islam. File Photo: Courtesy
    IPDC CEO Mominul to step down after 4 terms
  • Despite some positives like, changes in wordings the major things workers demand have not been reflected in the amendments. Photo: TBS
    Bangladesh could be target of US labour policy, warns Washington mission
  • Photo: Mohammad Minhaj Uddin
    Bangabandhu Tunnel: Tk4.11 crore in toll collected in first month
  • US dollar banknotes are seen in this illustration taken on 10 March 2023. Photo: Reuters
    Remittance dollar surges to Tk123, defying efforts to control it

Related News

  • US memorandum on labour standard: Nothing to worry about, Momen says
  • Henry Kissinger, controversial US statesman, dies at 100
  • Over 13,000 Bangladeshis currently studying in the US, an all-time high
  • Gold inches higher as investors focus on US inflation data
  • Oil prices ease on worries of waning demand in US and China

Features

(From Left) Sahid Hossain Mustakim, Sadia Ahmmed and Jishanul Islam are from United International University while Aadiba Tasneem Anam, who was not present at the event, studies at North South University. PHOTO: COURTESY

IPBlockchainPro: An invention by Bangladeshi students that could revolutionise the IP landscape

6h | Pursuit
Infograph: TBS

Elevate your leadership skills with free online courses

8h | Pursuit
Girls outperform boys in SSC and HSC. What prevents them from climbing higher? 

Girls outperform boys in SSC and HSC. What prevents them from climbing higher? 

14h | Panorama
Kissinger’s foreign policy and courses of action during his active years in office altered the lives of millions across the world. PHOTO: COLLECTED

Kissinger: A quiet end to a bloody legacy

17h | Panorama

More Videos from TBS

Small parties make big buzz

Small parties make big buzz

8h | TBS Stories
Saudi PIF to buy 10% stake in Heathrow Airport

Saudi PIF to buy 10% stake in Heathrow Airport

4h | TBS Economy
Are these the most thrilling hotels?

Are these the most thrilling hotels?

9h | TBS World
Is USA the obstacle to WB's climate finance?

Is USA the obstacle to WB's climate finance?

1d | TBS Economy
EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]